Search results
Bayer's (BAYRY) Arrhythmia Prevention Drug Gets Fast Track Tag
Zacks via Yahoo Finance· 12 months agoBayer's (BAYRY) oral FXIa inhibitor, asundexian, gets the FDA's Fast Track Designation, as a...
Bayer ends large blood thinner trial for ‘inferior efficacy’
BioPharma Dive via Yahoo Finance· 5 months agoBayer is stopping a large clinical trial testing its experimental blood thinner asundexian in people...
Bayer woes pile up as blood thinner drug trial fails
Reuters via Yahoo News· 5 months agoGermany's Bayer has aborted a large late-stage trial testing a new anti-clotting drug due to lack of efficacy, dealing a fresh blow to the embattled...
Pharma Stock Roundup: FDA Nod to ABBV's Rinvoq for New Indication & Other Updates
Zacks via Yahoo Finance· 11 months agoThis week an FDA panel voted in favor of approving Pfizer’s PFE experimental maternal RSV vaccine...
Bayer plans US expansion despite blood thinner drug setback
Reuters via Yahoo Finance· 4 months agoGermany's Bayer will continue its expansion into the U.S. despite its November announcement that its...
Bayer flags new blood thinner as $5 billion-plus opportunity
Reuters via Yahoo News· 1 year agoFRANKFURT (Reuters) -Bayer predicted on Tuesday its experimental drug against dangerous blood clots...
Bayer (BAYRY) Loses 28% in 2023: What to Expect in 2024?
Zacks via Yahoo Finance· 4 months agoBayer AG BAYRY put up a dismal performance in 2023, even though other players in the large-cap...
Bristol Myers Squibb, Bayer Stocks Hit The Deck On Blood Thinner Flops
Investor's Business Daily· 2 years agoBlood thinners produced separately by drug giants Bristol Myers Squibb and Bayer fell short of...
Bayer initiates asundexian Phase III study program
Reuters via Yahoo News· 2 years agoBERLIN (Reuters) - Germany's Bayer said on Sunday it was starting a Phase III study program to investigate the efficacy and safety of asundexian, an oral...
New Blood Thinners Will Prevent Blood Clots Without Causing Bleeding
The Wall Street Journal· 1 month agoJOURNAL REPORTS: HEALTH CARE A new class of anticoagulant drugs on the horizon is taking fresh aim...